Annual grants of up to $25,000 to support original research have been made available by the Australian Society of Antimicrobials (ASA). Grants may/may not be awarded annually at the discretion of the ASA Executive Committee. The following conditions apply:
The research funds are to be used for the project, as per the budget application only. ASA does not support an institution's infrastructure or overhead costs.
The application must be performed on line via the ASA website Research Grant Application Form and must include:
The grant application and CV will be assessed by a panel of at least six independent reviewers using a standardised scoring system. Applicants will be informed of the decision one week before the ASA annual scientific meeting "Antimicrobials 2018".
Click here for the Research Grant Application Form.
For further enquiries please contact the ASA secretary on firstname.lastname@example.org
Invasive Staphylococcus aureus infections and hospitalisations (ISAIAH) in Australian children: A two–year prospective, multicentre cohort study examining contemporary paediatric clinical and molecular epidemiology of S. aureus.
Christopher Blyth, University of Western Australia
Genomic Investigation of Carbapenem Resistant Enterobacteriaceae in Victoria
Norelle Sherry and Jason Kwong , University of Melbourne
Identification of the Pharmacokinetics Pharmacodynamics (PK/PD) Index and Targets of Fosfomycin for Bacterial Killing and Prevention of Resistance against Multidrug-resistant Pseudomonas aeruginsoa
Phillip Bergen, Monash University
Promiscuous Plasmids in Avian Pathogenic (APEC) and Faecal Escherichia coli (AFEC): How to Safeguard Australia
Justine Gibson, Queensland University
Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of
Bloodstream Infections Due to Ceftriaxone Non-Susceptible Escherichia coli and Klebsiella spp .
David Paterson, Queensland University
Complete Sequencing of Selected, Informative Multi-resistance Plasmids from Enterobacteriaceae
Sally Partridge, Westmead Hospital
VANESSA (VANcomycin Efficacy in Staphylococcal Sepsis in Australasia): A Prospective, Multi-centre, Observational Cohort Study of Outcomes in Staphylococcus aureus Bacteraemia
Natasha Holmes, Austin Health
|Copyright © 2004-2017 Australian Society of Antimicrobials|